OLBA HEALTHCARE : Summary of Financial Results for the third quarter 2021

Consolidated Financial Results

for the Nine Months Ended March 31, 2021

[Japanese GAAP]

April 30, 2021

Company name: OLBA HEALTHCARE HOLDINGS, Inc.

Stock exchange listing: Tokyo Stock Exchange

Code number: 2689

URL: https://www.olba.co.jp/

Representative: Yohei Maeshima, President COO

Contact: Nobuharu Murata, Managing Director and General Manager, Administrative Department

Phone: [phone]

Scheduled date of filing quarterly securities report: May 14, 2021

Scheduled date of commencing dividend payments: -

Availability of supplementary briefing material on quarterly financial results: Unavailable

Schedule of quarterly financial results briefing session: Not scheduled

(Amounts of less than one million yen are rounded down.)

1. Consolidated Financial Results for the Nine Months Ended March 31, 2021 (July 1, 2020 to March 31, 2021)

(1) Consolidated Operating Results

(% indicates changes from the previous year.)

Net sales

Operating income

Ordinary income

Net income

attributable to

owners of parent

Nine months ended

Million yen

%

Million yen

%

Million yen

%

Million yen

%

March 31, 2021

85,928

2.4

1,356

69.7

1,360

74.0

883

92.3

March 31, 2020

83,940

3.3

799

(14.5)

782

(16.8)

459

(24.2)

(Note) Comprehensive income: Nine months ended March 31, 2021: ¥872 million [121.2%]

Nine months ended March 31, 2020: ¥394 million [(23.1)%]

Basic earnings

Diluted earnings

per share

per share

Nine months ended

Yen

Yen

March 31, 2021

145.30

－

March 31, 2020

81.33

－

(2) Consolidated Financial Position

Total assets

Net assets

Equity ratio

Million yen

Million yen

%

As of March 31, 2021

40,888

7,874

19.3

As of June 30, 2020

33,683

7,281

21.6

(Reference) Equity: As of March 31, 2021: ¥7,874 million

As of June 30, 2020: ¥7,281 million

2. Dividends

Annual dividends

1st

2nd

3rd

Year-end

Total

quarter-end

quarter-end

quarter-end

Fiscal year ended June 30, 2020

Yen

Yen

Yen

Yen

Yen

－

0.00

－

45.00

45.00

Fiscal year ending June 30, 2021

－

0.00

－

Fiscal year ending June 30, 2021

45.00

45.00

(Forecast)

(Note) Revision to the forecast for dividends announced most recently: None

3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 2021 (July 1, 2020 to June 30, 2021) (% indicates changes from the previous corresponding period.)

							Net income	Basic earnings
	Net sales		Operating income	Ordinary income	attributable to
		per share
							owners of parent
	Million yen	%	Million yen	%	Million yen	%	Million yen	%	Yen
Full year	114,114	5.8	1,440	55.3	1,441	59.2	931	185.3	153.11

(Note) Revision to the financial results forecast announced most recently: None

Notes:

1. Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting in changes in scope of consolidation): None
   Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name)
2. Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: None
3. Changes in accounting policies, changes in accounting estimates and retrospective restatement
4. 1. Changes in accounting policies due to the revision of accounting standards: None
   2. Changes in accounting policies other than 1) above: None
   3. Changes in accounting estimates: None
   4. Retrospective restatement: None

1. Total number of issued shares (common stock)
2. 1. Total number of issued shares at the end of the period (including treasury stock): March 31, 2021: 6,250,000 shares
      June 30, 2020: 6,250,000 shares
   2. Total number of treasury stock at the end of the period:

March 31, 2021: 167,676 shares

June 30, 2020: 167,605 shares

3) Average number of shares during the period:

Nine months ended March 31, 2021: 6,082,381 shares

Nine months ended March 31, 2020: 5,650,715shares

As of March 31, 2021, 116,600 shares of the Company's stock held by the Board Benefit Trust were included in treasury stock.

• Quarterly financial results are outside the scope of the quarterly review procedures conducted by a certified public accountant or audit corporation.
• Explanation of the proper use of financial results forecast and other notes

• The figures forecasted above are based on information that is available as of the date of publication of this document, and contain a wide range of uncertain factors. Actual results may differ significantly from these figures due to factors such as changes in the business environment.
• The Company changed its name from KAWANISHI HOLDINGS, INC. to OLBA HEALTHCARE HOLDINGS, Inc. on January 1, 2021.